The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

[ad_1] Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael … Read More

Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth

[ad_1] Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but … Read More

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

[ad_1] Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. … Read More

Biden administration’s Medicare drug price negotiations will face major tests in 2024

[ad_1] Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna … Read More

Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024

[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers … Read More

The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead

[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs … Read More

If you can’t build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space

[ad_1] Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all … Read More